Concepedia
Statistics
Publications
10
Citations
392
H-Index
Active since
1994
Affiliations
The Ohio State University(Current)
Dana-Farber Cancer Institute
Harvard University
Hackensack University Medical Center
Emory University
Sheetal Shah is an author at The Ohio State University specializing in medicine, pharmacotherapy, and lenalidomide therapy.
Publications per year
1994–2023
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
Uwe Platzbecker, Valeria Santini, Pierre Fenaux et al. · The Lancet · 2023 · 132 citations
Medicine, Hematology, Pharmacology +8
Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia
Clemens‐Martin Wendtner, Peter Hillmen, Daruka Mahadevan et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 59 citations
Pharmacy, Oncology, Pharmacotherapy +16
Cloning by synteny: identifying C.briggse homologues of C.elegans genes
Patricia E. Kuwabara, Sheetal Shah · Nucleic Acids Research · 1994 · 58 citations · Full text
Life Sciences, Genetics, Molecular Biology +14
Spiroindolines Identify the Vesicular Acetylcholine Transporter as a Novel Target for Insecticide Action
Ann E. Sluder, Sheetal Shah, Jérôme Cassayre et al. · PLoS ONE · 2012 · 57 citations · Full text
Life Sciences, Entomology, Medicinal Chemistry +14
MM-005: A Phase 1 Trial Of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone (PVD) In Relapsed and/Or Refractory Multiple Myeloma (RRMM)
Paul G. Richardson, Craig C. Hofmeister, David S. Siegel et al. · Blood · 2013 · 19 citations
Medicine, Oncology, Pharmacotherapy +15
1–5 of 10